Header Logo

Connection

MEGUMI MATHISON to Animals

Back to Details
This is a "connection" page, showing publications MEGUMI MATHISON has written about Animals.
MEGUMI MATHISON
Connection Strength
0.282
Animals
  1. Fibroblast transition to an endothelial "trans" state improves cell reprogramming efficiency. Sci Rep. 2021 11 19; 11(1):22605.
    View in: PubMed
    Score: 0.045
  2. Heart regeneration: The endothelial cell comes first. J Thorac Cardiovasc Surg. 2018 03; 155(3):1128-1129.
    View in: PubMed
    Score: 0.033
  3. Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail. J Thorac Cardiovasc Surg. 2017 11; 154(5):1601-1610.e3.
    View in: PubMed
    Score: 0.033
  4. In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration. J Thorac Cardiovasc Surg. 2017 02; 153(2):329-339.e3.
    View in: PubMed
    Score: 0.031
  5. "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1656-1664.e2.
    View in: PubMed
    Score: 0.026
  6. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 2012 Dec; 1(6):e005652.
    View in: PubMed
    Score: 0.024
  7. Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential. Sci Rep. 2024 10 15; 14(1):24182.
    View in: PubMed
    Score: 0.014
  8. p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation. Sci Rep. 2022 07 06; 12(1):11416.
    View in: PubMed
    Score: 0.012
  9. Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming. J Am Heart Assoc. 2021 12 21; 10(24):e022659.
    View in: PubMed
    Score: 0.011
  10. Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium. Biomater Sci. 2020 Sep 15; 8(18):5061-5070.
    View in: PubMed
    Score: 0.010
  11. Enhanced Generation of Induced Cardiomyocytes Using a Small-Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming. J Am Heart Assoc. 2020 06 16; 9(12):e015686.
    View in: PubMed
    Score: 0.010
  12. p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells. J Thorac Cardiovasc Surg. 2018 08; 156(2):556-565.e1.
    View in: PubMed
    Score: 0.009
  13. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. J Hematol Oncol. 2017 10 03; 10(1):159.
    View in: PubMed
    Score: 0.008
  14. MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1. J Am Heart Assoc. 2016 11 10; 5(11).
    View in: PubMed
    Score: 0.008
  15. Extracellular matrix scaffold for cardiac repair. Circulation. 2005 Aug 30; 112(9 Suppl):I135-43.
    View in: PubMed
    Score: 0.004
  16. A clinically relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materials. Cardiovasc Revasc Med. 2005 Jul-Sep; 6(3):113-20.
    View in: PubMed
    Score: 0.004
  17. Diagnosis of cardiac allograft rejection by the detection of circulating plasma cardiac myosin light chains. Jpn J Surg. 1990 Mar; 20(2):212-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.